Skip to content
healthcare.dev

Pentazocine and naloxone

NDC 0591-0395, Pentazocine hydrochloride and naloxone hydrochloride, tablet, from Actavis Pharma, Inc..

Product NDC
0591-0395
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074736
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-0395 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PENTAZOCINE HYDROCHLORIDE50 mg/1
  • NALOXONE HYDROCHLORIDE.5 mg/1

Pharmacologic classes

Competitive Opioid Antagonists [MoA]; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist/Antagonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
0591-0395-0100591039501100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a28450a0-ac93-4235-b9a6-58cdf24773cb
  • NADAC price for package 00591039501

    GET /v1/drugs/nadac/00591039501

Use it

Look up 0591-0395 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-0395 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-0395. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.